MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.470
-0.110 (-6.96%)
At close: Dec 5, 2025, 4:00 PM EST
1.480
+0.010 (0.68%)
After-hours: Dec 5, 2025, 7:37 PM EST
MaxCyte Stock Forecast
MXCT's stock price has decreased by -59.95% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for MaxCyte stock have an average target of 7.50, with a low estimate of 6.00 and a high estimate of 9.00. The average target predicts an increase of 410.20% from the current stock price of 1.47.
Analyst Consensus: Buy
* Price targets were last updated on Jul 22, 2025.
Analyst Ratings
The average analyst rating for MaxCyte stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 11, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 7, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $6 | Buy | Initiates | $6 | +308.16% | Jul 22, 2025 |
| Stifel | Stifel | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +512.24% | Mar 12, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +648.30% | Apr 23, 2024 |
Financial Forecast
Revenue This Year
36.28M
from 38.63M
Decreased by -6.09%
Revenue Next Year
40.15M
from 36.28M
Increased by 10.69%
EPS This Year
-0.41
from -0.39
EPS Next Year
-0.27
from -0.41
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 37.9M | 45.0M | ||||
| Avg | 36.3M | 40.2M | ||||
| Low | 33.9M | 36.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.9% | 24.2% | ||||
| Avg | -6.1% | 10.7% | ||||
| Low | -12.3% | 1.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.41 | -0.17 | |
| Avg | -0.41 | -0.27 | |
| Low | -0.40 | -0.44 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.